TY - JOUR
T1 - Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations
AU - Hansen, Marcus Celik
AU - Nyvold, Charlotte Guldborg
AU - Roug, Anne Stidsholt
AU - Kjeldsen, Eigil
AU - Villesen, Palle
AU - Nederby, Line
AU - Hokland, Peter
PY - 2015/5
Y1 - 2015/5
N2 - We describe a comprehensive molecular analysis of a pair of monozygotic twins, who came to our attention when one experienced amaurosis fugax and was diagnosed with JAK2+ polycythaemia vera. He (Twin A) was also found to have an asymptomatic B-cell chronic lymphocytic leukaemia (B-CLL). Although JAK2-, Twin B was subsequently shown to have a benign monoclonal B-cell lymphocytosis (MBL). Flow cytometric and molecular analyses of the B-cell compartments revealed different immunoglobulin light and heavy chain usage in each twin. We hypothesized that whole exome sequencing could help delineating the pattern of germline B-cell disorder susceptibility and reveal somatic mutations potentially contributing to the differential patterns of pre-malignancy. Comparing bone marrow cells and T cells and employing in-house engineered integrative analysis, we found aberrations in Twin A consistent with a myeloid neoplasm, i.e. in TET2, RUNX1, PLCB1 and ELF4. Employing the method for detecting high-ranking variants by extensive annotation and relevance scoring, we also identified shared germline variants in genes of proteins interacting with B-cell receptor signalling mediators and the WNT-pathway, including IRF8, PTPRO, BCL9L, SIT1 and SIRPB1, all with possible implications in B-cell proliferation. Similar patterns of IGHV-gene usage to those demonstrated here have been observed in inherited acute lymphoblastic leukaemia. Collectively, these findings may help in facilitating identification of putative master gene(s) involved in B-cell proliferations in general and MBL and B-CLL in particular.
AB - We describe a comprehensive molecular analysis of a pair of monozygotic twins, who came to our attention when one experienced amaurosis fugax and was diagnosed with JAK2+ polycythaemia vera. He (Twin A) was also found to have an asymptomatic B-cell chronic lymphocytic leukaemia (B-CLL). Although JAK2-, Twin B was subsequently shown to have a benign monoclonal B-cell lymphocytosis (MBL). Flow cytometric and molecular analyses of the B-cell compartments revealed different immunoglobulin light and heavy chain usage in each twin. We hypothesized that whole exome sequencing could help delineating the pattern of germline B-cell disorder susceptibility and reveal somatic mutations potentially contributing to the differential patterns of pre-malignancy. Comparing bone marrow cells and T cells and employing in-house engineered integrative analysis, we found aberrations in Twin A consistent with a myeloid neoplasm, i.e. in TET2, RUNX1, PLCB1 and ELF4. Employing the method for detecting high-ranking variants by extensive annotation and relevance scoring, we also identified shared germline variants in genes of proteins interacting with B-cell receptor signalling mediators and the WNT-pathway, including IRF8, PTPRO, BCL9L, SIT1 and SIRPB1, all with possible implications in B-cell proliferation. Similar patterns of IGHV-gene usage to those demonstrated here have been observed in inherited acute lymphoblastic leukaemia. Collectively, these findings may help in facilitating identification of putative master gene(s) involved in B-cell proliferations in general and MBL and B-CLL in particular.
KW - Chronic lymphocytic leukaemia
KW - Customized exome analysis
KW - JAK2 mutation
KW - Monoclonal B-cells
KW - Monozygotic twins
KW - Genetic Predisposition to Disease
KW - Somatic Hypermutation, Immunoglobulin
KW - Humans
KW - Lymphocytosis/genetics
KW - Immunophenotyping
KW - Male
KW - Twins, Monozygotic
KW - Exome
KW - Comparative Genomic Hybridization
KW - Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis
KW - Germ-Line Mutation
KW - Immunoglobulin Heavy Chains/genetics
KW - Aged
KW - Precancerous Conditions
U2 - 10.1111/bjh.13305
DO - 10.1111/bjh.13305
M3 - Journal article
C2 - 25752595
SN - 0007-1048
VL - 169
SP - 391
EP - 400
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 3
ER -